TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).


Options:
A: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal Red Blood Cell Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Red Blood Cell Transfusion Strategy | Intervention Type: OTHER; Name: Liberal Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive Red Blood Cell Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
B: Arm Label: Single-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Arm Label: Multiple-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Intervention Type: BIOLOGICAL; Name: Blood Transfusion; Assigned to Arm(s): Multiple-Unit Blood Transfusion Protocol, Single-Unit Blood Transfusion Protocol
C: Arm Label: Restrictive transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal transfusion strategy
D: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Strengthening the Evidence Base on Effective scHool Based intErventions for pRomoting Adolescent Health (SEHER)
Brief Summary: SEHER- Strengthening Evidence base on scHool-based intErventions for pRomoting adolescent health, seeks to develop and evaluate a school based adolescent health promotion intervention delivered by two different delivery agents viz. teacher-as-SEHER Mitra (TSM) and lay school counsellor called as SEHER Mitra (SM) in government-run secondary schools in Bihar, India. SEHER will implement a three armed clustered randomised trial (CRT) to evaluate the effectiveness and cost-effectiveness of these two models compared with the Tarang-Adolescence Education Programme (usual care) implemented by the State Government of Bihar. The hypothesis is that both interventions, compared to the control arm, will lead to a greater impact on school climate (school connectedness and relationship with teachers and fellow students). In addition, the interventions will increase the knowledge, attitude and awareness, and promoting healthy behaviours in youth on reproductive and sexual health outcomes, mental health and substance use, and gender related attitudes and violence. It is hypothesized that the addition of more resource intensive component (the SM arm) will be associated with the best outcomes.


Options:
A: Arm Label: TSM Arm; Type: EXPERIMENTAL; Interventions: Other: Tarang Adolescence Education programme, Other: SEHER Intervention | Arm Label: SM Arm; Type: EXPERIMENTAL; Interventions: Other: Tarang Adolescence Education programme, Other: SEHER Intervention | Arm Label: Comparison Arm; Type: OTHER; Interventions: Other: Tarang Adolescence Education programme | Intervention Type: OTHER; Name: Tarang Adolescence Education programme; Assigned to Arm(s): Comparison Arm, SM Arm, TSM Arm | Intervention Type: OTHER; Name: SEHER Intervention; Assigned to Arm(s): SM Arm, TSM Arm
B: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The TEA intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The TEA intervention; Assigned to Arm(s): intervention
C: Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Other: Education of medical humanities | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education of medical humanities; Assigned to Arm(s): intervention group
D: Arm Label: THPP-I; Type: EXPERIMENTAL; Interventions: Behavioral: THPP-I, Behavioral: EUC | Arm Label: Enhanced usual care (EUC); Type: OTHER; Interventions: Behavioral: EUC | Intervention Type: BEHAVIORAL; Name: THPP-I; Assigned to Arm(s): THPP-I | Intervention Type: BEHAVIORAL; Name: EUC; Assigned to Arm(s): Enhanced usual care (EUC), THPP-I

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Gene Therapy, Open-label, Dose-escalation Study of PF-06838435 (SPK-9001) [Adeno-associated Viral Vector With Human Factor IX Gene] in Subjects With Hemophilia B
Brief Summary: A Phase 1/2, Open-Label, Non-Randomized, Dose-Escalation Study of SPK-9001 in Subjects with Hemophilia B.


Options:
A: N/A
B: Arm Label: Fixed Weekly Interval; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc), Drug: rFIX | Arm Label: Individualized Interval; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Arm Label: On Demand; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Arm Label: Surgery; Type: EXPERIMENTAL; Interventions: Drug: Factor IX (rFIXFc) | Intervention Type: DRUG; Name: Factor IX (rFIXFc); Assigned to Arm(s): Fixed Weekly Interval, Individualized Interval, On Demand, Surgery | Intervention Type: DRUG; Name: rFIX; Assigned to Arm(s): Fixed Weekly Interval
C: Arm Label: SPK-9001; Type: EXPERIMENTAL; Interventions: Biological: SPK-9001 | Intervention Type: BIOLOGICAL; Name: SPK-9001; Assigned to Arm(s): SPK-9001
D: Arm Label: Prophylaxis; Type: EXPERIMENTAL; Interventions: Biological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, Biological: PEGylated Recombinant Factor VIII | Arm Label: On-demand; Type: EXPERIMENTAL; Interventions: Biological: PEGylated Recombinant Factor VIII | Intervention Type: BIOLOGICAL; Name: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): Prophylaxis | Intervention Type: BIOLOGICAL; Name: PEGylated Recombinant Factor VIII; Assigned to Arm(s): On-demand

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dispensing Study to Assess the Visual Performance of Optimised Prototype Contact Lenses
Brief Summary: The aim of this study is to assess the visual performance of multiple optimised prototype soft contact lens designs compared to commercially available contact lenses.


Options:
A: Arm Label: Presbyope group; Type: OTHER; Interventions: Device: Etafilcon A, Device: Nelfilcon A, Device: Nesofilcon A, Device: Somofilcon A, Device: 58% Poly-HEMA | Arm Label: Non-Presbyope group; Type: OTHER; Interventions: Device: Etafilcon A, Device: Nelfilcon A, Device: Omafilcon A | Intervention Type: DEVICE; Name: Etafilcon A; Assigned to Arm(s): Non-Presbyope group, Presbyope group | Intervention Type: DEVICE; Name: Etafilcon A; Assigned to Arm(s): Presbyope group | Intervention Type: DEVICE; Name: Nelfilcon A; Assigned to Arm(s): Presbyope group | Intervention Type: DEVICE; Name: Nesofilcon A; Assigned to Arm(s): Presbyope group | Intervention Type: DEVICE; Name: Nelfilcon A; Assigned to Arm(s): Non-Presbyope group | Intervention Type: DEVICE; Name: Etafilcon A; Assigned to Arm(s): Non-Presbyope group | Intervention Type: DEVICE; Name: Somofilcon A; Assigned to Arm(s): Presbyope group | Intervention Type: DEVICE; Name: 58% Poly-HEMA; Assigned to Arm(s): Presbyope group | Intervention Type: DEVICE; Name: Omafilcon A; Assigned to Arm(s): Non-Presbyope group
B: Arm Label: 1-Day ACUVUE TruEye contact lens users; Type: N/A; Interventions: Device: narafilcon B daily disposable soft contact lenses | Arm Label: 1-Day ACUVUE MOIST contact lens users; Type: N/A; Interventions: Device: etafilcon A daily disposable soft contact lenses | Intervention Type: DEVICE; Name: narafilcon B daily disposable soft contact lenses; Assigned to Arm(s): 1-Day ACUVUE TruEye contact lens users | Intervention Type: DEVICE; Name: etafilcon A daily disposable soft contact lenses; Assigned to Arm(s): 1-Day ACUVUE MOIST contact lens users
C: Arm Label: Hyperosmolarity group; Type: EXPERIMENTAL; Interventions: Other: Daily-disposable soft contact lens | Arm Label: Normal osmolarity; Type: EXPERIMENTAL; Interventions: Other: Daily-disposable soft contact lens | Intervention Type: OTHER; Name: Daily-disposable soft contact lens; Assigned to Arm(s): Hyperosmolarity group, Normal osmolarity
D: Arm Label: ReNu Multiplus and lotrafilcon A lenses; Type: ACTIVE_COMPARATOR; Interventions: Device: lotrafilcon A contact lenses, Device: Renu Multiplus | Arm Label: Clear Care solution and lotrafilcon A lenses; Type: ACTIVE_COMPARATOR; Interventions: Device: lotrafilcon A contact lenses, Device: Clear Care | Intervention Type: DEVICE; Name: lotrafilcon A contact lenses; Assigned to Arm(s): Clear Care solution and lotrafilcon A lenses, ReNu Multiplus and lotrafilcon A lenses | Intervention Type: DEVICE; Name: Renu Multiplus; Assigned to Arm(s): ReNu Multiplus and lotrafilcon A lenses | Intervention Type: DEVICE; Name: Clear Care; Assigned to Arm(s): Clear Care solution and lotrafilcon A lenses

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Personalized Extracorporeal Biofeedback Device for Pelvic Floor Muscle Training on Post-prostatectomy Incontinence
Brief Summary: To evaluate the efficacy of postoperative pelvic floor muscle training using personalized extracorporeal biofeedback device among patients with post-prostatectomy incontinence


Options:
A: Arm Label: Transcutaneous perineal stimulation; Type: EXPERIMENTAL; Interventions: Other: Transcutaneous perineal stimulation | Arm Label: Anal stimulation; Type: ACTIVE_COMPARATOR; Interventions: Other: Anal stimulation | Intervention Type: OTHER; Name: Transcutaneous perineal stimulation; Assigned to Arm(s): Transcutaneous perineal stimulation | Intervention Type: OTHER; Name: Anal stimulation; Assigned to Arm(s): Anal stimulation
B: Arm Label: Kegel exercise education; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Extracorporeal biofeedback device; Type: EXPERIMENTAL; Interventions: Device: Extracorporeal biofeedback device (Any Kegel) | Intervention Type: DEVICE; Name: Extracorporeal biofeedback device (Any Kegel); Assigned to Arm(s): Extracorporeal biofeedback device
C: Arm Label: study group; Type: ACTIVE_COMPARATOR; Interventions: Other: whole body vibration | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: whole body vibration; Assigned to Arm(s): study group
D: Arm Label: PILATES; Type: EXPERIMENTAL; Interventions: Other: Pilates | Arm Label: PFMT and AES; Type: ACTIVE_COMPARATOR; Interventions: Other: PFMT and AES | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Pilates; Assigned to Arm(s): PILATES | Intervention Type: OTHER; Name: PFMT and AES; Assigned to Arm(s): PFMT and AES | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Single-Blind, Randomized, Placebo-Controlled Trial of Human Fecal Microbiota Transplantation for the Therapy of Pediatric Ulcerative Colitis and Inflammatory Bowel Disease Unclassified
Brief Summary: The PediFETCh study is a pilot trial designed to assess the feasibility of fecal microbiota transplants for the therapy of pediatric ulcerative colitis (UC) and pediatric inflammatory bowel disease-unclassified (IBD-U). Investigators will test the hypothesis that a protocol of twice-weekly retention enemas delivered over six weeks, using fecal transplant material from a healthy donor, will improve clinical and biological disease markers in patients with pediatric UC or IBD-U.


Options:
A: Arm Label: Fecal Microbiota Enema; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Enema | Arm Label: Normal Saline Enema; Type: PLACEBO_COMPARATOR; Interventions: Biological: Normal Saline Enema | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Enema; Assigned to Arm(s): Fecal Microbiota Enema | Intervention Type: BIOLOGICAL; Name: Normal Saline Enema; Assigned to Arm(s): Normal Saline Enema
B: Arm Label: co-transplantation of FMT and pectin; Type: EXPERIMENTAL; Interventions: Other: co-transplantation of FMT and pectin | Arm Label: single fecal microbiota transplantation; Type: ACTIVE_COMPARATOR; Interventions: Other: single fecal microbiota transplantation | Arm Label: give pectin 20g/d; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: pure give pectin 20g/d for five days | Intervention Type: OTHER; Name: co-transplantation of FMT and pectin; Assigned to Arm(s): co-transplantation of FMT and pectin | Intervention Type: OTHER; Name: single fecal microbiota transplantation; Assigned to Arm(s): single fecal microbiota transplantation | Intervention Type: DIETARY_SUPPLEMENT; Name: pure give pectin 20g/d for five days; Assigned to Arm(s): give pectin 20g/d
C: Arm Label: Colonoscopy; Type: EXPERIMENTAL; Interventions: Drug: Fecal Microbiota Transplant (FMT) | Arm Label: Nasogastric Tube (NGT); Type: EXPERIMENTAL; Interventions: Drug: Fecal Microbiota Transplant (FMT) | Intervention Type: DRUG; Name: Fecal Microbiota Transplant (FMT); Assigned to Arm(s): Colonoscopy, Nasogastric Tube (NGT)
D: Arm Label: Fecal Microbiota Transplantation; Type: ACTIVE_COMPARATOR; Interventions: Biological: Fecal Microbiota Transplantation | Arm Label: Sham Fecal Microbiota Transplantation; Type: SHAM_COMPARATOR; Interventions: Biological: Sham Fecal Microbiota Transplantation | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Transplantation; Assigned to Arm(s): Fecal Microbiota Transplantation | Intervention Type: BIOLOGICAL; Name: Sham Fecal Microbiota Transplantation; Assigned to Arm(s): Sham Fecal Microbiota Transplantation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Single-Blind, Randomized, Placebo-Controlled Trial of Human Fecal Microbiota Transplantation for the Therapy of Pediatric Ulcerative Colitis and Inflammatory Bowel Disease Unclassified
Brief Summary: The PediFETCh study is a pilot trial designed to assess the feasibility of fecal microbiota transplants for the therapy of pediatric ulcerative colitis (UC) and pediatric inflammatory bowel disease-unclassified (IBD-U). Investigators will test the hypothesis that a protocol of twice-weekly retention enemas delivered over six weeks, using fecal transplant material from a healthy donor, will improve clinical and biological disease markers in patients with pediatric UC or IBD-U.


Options:
A: Arm Label: placebo enema; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo enema | Arm Label: Fecal transplant from an unrelated donor; Type: ACTIVE_COMPARATOR; Interventions: Other: Fecal transplant | Intervention Type: OTHER; Name: Fecal transplant; Assigned to Arm(s): Fecal transplant from an unrelated donor | Intervention Type: OTHER; Name: Placebo enema; Assigned to Arm(s): placebo enema
B: Arm Label: Fecal Microbiota Enema; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Enema | Arm Label: Normal Saline Enema; Type: PLACEBO_COMPARATOR; Interventions: Biological: Normal Saline Enema | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Enema; Assigned to Arm(s): Fecal Microbiota Enema | Intervention Type: BIOLOGICAL; Name: Normal Saline Enema; Assigned to Arm(s): Normal Saline Enema
C: Arm Label: Metronidazole+doxycylcine+terbinafine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole, Drug: Doxycycline, Drug: Terbinafine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole+doxycylcine+terbinafine | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Metronidazole+doxycylcine+terbinafine | Intervention Type: DRUG; Name: Terbinafine; Assigned to Arm(s): Metronidazole+doxycylcine+terbinafine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: colonoscope via of FMT; Type: N/A; Interventions: Device: colonoscope | Arm Label: Transendoscopic enteral tubing; Type: N/A; Interventions: Device: transendoscopic enteral tubing | Intervention Type: DEVICE; Name: transendoscopic enteral tubing; Assigned to Arm(s): Transendoscopic enteral tubing | Intervention Type: DEVICE; Name: colonoscope; Assigned to Arm(s): colonoscope via of FMT

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschoolers
Brief Summary: Socioeconomic disparities in early childhood place low-income children at 1.5 to 2 times higher risk for obesity compared to middle- to upper-income children. Obesity interventions have turned toward the promotion of family mealtimes. This study will test the effects of 6 intervention components reflecting differing levels of supports to ultimately reduce childhood obesity prevalence and increase the frequency of healthy family mealtimes and improve dietary quality. The investigators will test 6 intervention components in Phase 1 (Screening Phase), resulting in the implementation and evaluation via a randomized controlled trial of a "final" intervention model in Phase 2 (Confirming Phase). The investigators hypothesize that providing low-income families with effective supports to enhance family capability to plan and implement family mealtimes will lead to improvements in children's adiposity indices, dietary quality and frequency of family meals.


Options:
A: Intervention Type: BEHAVIORAL; Name: Nutritional and life style counseling; Assigned to Arm(s): N/A
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
C: Arm Label: Experimental: Phase 1 Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 1 Mealtime support activities; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Arm Label: Experimental: Phase 2- Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 2- Meal Delivery and Receipt of Cookware; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Intervention Type: BEHAVIORAL; Name: Mealtime Supports; Assigned to Arm(s): Experimental: Phase 1 Mealtime support activities, Experimental: Phase 2- Meal Delivery and Receipt of Cookware | Intervention Type: BEHAVIORAL; Name: Usual Exposure; Assigned to Arm(s): Experimental: Phase 1 Usual Exposure, Experimental: Phase 2- Usual Exposure
D: Arm Label: Individualized dietetic intervention; Type: OTHER; Interventions: Behavioral: Individualized dietetic intervention-eating habits | Intervention Type: BEHAVIORAL; Name: Individualized dietetic intervention-eating habits; Assigned to Arm(s): Individualized dietetic intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschoolers
Brief Summary: Socioeconomic disparities in early childhood place low-income children at 1.5 to 2 times higher risk for obesity compared to middle- to upper-income children. Obesity interventions have turned toward the promotion of family mealtimes. This study will test the effects of 6 intervention components reflecting differing levels of supports to ultimately reduce childhood obesity prevalence and increase the frequency of healthy family mealtimes and improve dietary quality. The investigators will test 6 intervention components in Phase 1 (Screening Phase), resulting in the implementation and evaluation via a randomized controlled trial of a "final" intervention model in Phase 2 (Confirming Phase). The investigators hypothesize that providing low-income families with effective supports to enhance family capability to plan and implement family mealtimes will lead to improvements in children's adiposity indices, dietary quality and frequency of family meals.


Options:
A: Arm Label: 1M0.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: 1M1.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: 3M0.5; Type: EXPERIMENTAL; Interventions: Other: Timing of Diet and Flavor Experience | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Timing of Diet and Flavor Experience; Assigned to Arm(s): 1M0.5, 1M1.5, 3M0.5
B: Arm Label: Experimental: Phase 1 Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 1 Mealtime support activities; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Arm Label: Experimental: Phase 2- Usual Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Usual Exposure | Arm Label: Experimental: Phase 2- Meal Delivery and Receipt of Cookware; Type: EXPERIMENTAL; Interventions: Behavioral: Mealtime Supports | Intervention Type: BEHAVIORAL; Name: Mealtime Supports; Assigned to Arm(s): Experimental: Phase 1 Mealtime support activities, Experimental: Phase 2- Meal Delivery and Receipt of Cookware | Intervention Type: BEHAVIORAL; Name: Usual Exposure; Assigned to Arm(s): Experimental: Phase 1 Usual Exposure, Experimental: Phase 2- Usual Exposure
C: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
D: Arm Label: AA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Arm Label: HA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Intervention Type: BEHAVIORAL; Name: Increase vegetable intake in pre-school children; Assigned to Arm(s): AA - Increase vegetable intake, HA - Increase vegetable intake

Answer: B